Asthma control, treatment patterns and health care utilization, based on co-morbidity during 2011-2014
- Conditions
- Diseases of th respiratory system
- Registration Number
- KCT0001244
- Lead Sponsor
- Ewha Clinical Trial Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 200
All satisfying subjects, below category 1 to 4.
1) The subjects of newly diagnosed asthma or being treated as already diagnosed asthma over 20 years old
2) The subjects being followed up at Division of Pulmonary and Critical Care Medicine, Ewha Womans University as an out patients basis or in patients basis during 2011 to 2014 April
3) The subjects using inhaled corticosteroid or leukotriene modifier
4) The subjects, who received asthma managements for at least more than 6 months during the study period and over 3 months per year since 2011 to Apr 2014, the observatory period
1) Ever treatment of severe respiratory infection
2) Current infection of pulmonary tuberculosis or nontuberculous mycobacterial infection
3) HIV infected patient
4) ICU cared subjects due to other reasons excluding asthma within 2 years before from asthma management
5) The subjects under the other clinical trial within 1 months during study period
6) The subjects, accompanied severe interstitial lung disease
7) The subjects receiving home oxygen therapy
8) The subjects, taken mechanical ventilation during study period regardless of any cause
9) The subjects of congenital anomaly
10) Resident in chronic care facility due to severe degree of chronic illness during study period
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The evaluation of asthma control according to severity of co-morbidity in bronchial asthma
- Secondary Outcome Measures
Name Time Method Treatment medication patterns according to severity of co-morbidity in bronchial asthma;The evaluation of health care utilization according to severity of co-morbidity in bronchial asthma